AstraZeneca is a global pharmaceutical company harnessing the power of science to make health happen for people, society and the planet. We follow the science to create transformative change, primarily for the treatment of diseases in four main therapy areas – Oncology, Cardiovascular & Metabolic Disease, Respiratory and Rare Disease. We are also selectively active in the areas of autoimmunity, neuroscience and infection.
AstraZeneca Hong Kong oversees both the Hong Kong and Macau markets and attaches a strong importance to them. Since its inception in 1990, AstraZeneca Hong Kong has delivered many life-changing medicines that have transformed the lives of patients and have revolutionized disease treatment in Hong Kong and Macau.

Zai Lab is a patient-focused, innovative, commercial-stage, global biopharmaceutical company based in China and the U.S. We are focused on bringing best-in-class and first-in-class medicines for oncology, autoimmune disorders, infectious diseases and neurological disorders to patients in greater China and around the world.